Alfacam in Rough Waters with Creditors

Belgian firm Alfacam is now in rough waters financially after its credit line was cut off for breach of covenants.


Dish Network to offer senior notes

Dish Network would offer senior notes amounting to US$2.3 billion, double its previous announcement.

IPOs in Gulf Region Run High Expectations

DAMAC Properties would be listing publicly in the Dubai bourse amidst high interest for IPOs in the region.

INCJ invests US$12M in Midokura

Midokura's network development software boosts its capital infusion with US$12M from INCJ and US$5.2M for other investors.


Latest News

PT Saratoga Investama Sedaya and PT Mitra Pinasthika Mustika would be listed for their individual IPOs in Indonesia's bourse this year.
Bostjan Jazbec is the new central bank governor of Slovenia. Bostjan Jazbec, the International Monetary Fund expert has been appointed as the central bank governor of Slovenia.
AstraZeneca purchases AlphaCore and its up and coming cholesterol drugs. AstraZeneca purchased through private placement US biotech company AlphaCore Pharma.
Astorg Partners leads the consortium that will purchase Canberra from Areva. Areva. the top nuclear reactor builder of France announced that it would be selling its nuclear radiation measurement subsidiary to a private equity group.
Vodafone shares tumble after Verizon denies takeover talk. Vodafone share values fell after Verizon Communications denied rumors of a takeover of its joint venture.
British Petroleum, in the wake of the 2010 oil spill liabilities, is selling off its wind farm operations in the US reportedly at US$1.5 billion.
HighMark Funds, the mutual fund arm of UnionBanCal is being sold to Nationwide Financial and Reich & Tang.
Cammeby's International Group would be purchasing the Monterey for the sum of US$250 million. One of the largest apartment towers in Manhattan would be purchased by Rubin Schron, Related Cos is selling one of its assets to the part owner of the Woolworth Building.
Optimer Pharmaceuticals is subject to many possible offers from other drug companies. The antibiotics pharmaceutical maker Optimer Pharmaceuticals Inc has been the subject of interest from GlaxoSmithKline Plc and Astellas Pharma Inc of Japan.
The Bronx Parking Development Corp skipped payment of interest to its bondholders and is now contemplating bankruptcy protection.